Definium Therapeutics Inc. Common Shares vs Welltower Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.01 (market cap $4.59B), while Welltower Inc. Common Stock trades at $224.67 (market cap $159.33B). The key difference: Welltower Inc. Common Stock is far larger — about 34.7× Definium Therapeutics Inc. Common Shares's market cap, and Welltower Inc. Common Stock pays a 1.54% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Welltower Inc. Common Stock for 0 Days on average.
| DFTX | WELL | |
|---|---|---|
Market Cap | $4.59B | $159.33B |
Volume | 2,103,937 | 2,484,986 |
Sector | Health | Real Estate |
52-Week High | $48.45 | $252.07 |
52-Week Low | $10.68 | $165.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $177.09B |
Dividend Yield | — | 1.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.
Read more on WELL →